
Synopsys, Inc. SNPS will release its financial results for the first quarter fiscal year 2025, after the closing bell, on Wednesday, Feb. 26, 2025.
Analysts expect the Sunnyvale, California-based company to report quarterly earnings at $2.79 per share, down from $3.56 per share in the year-ago period. Synopsys projects quarterly revenue of $1.45 billion, compared to $1.65 billion a year earlier, according to data from Benzinga Pro.
On Dec. 4, 2024, Synopsys issued first-quarter guidance below estimates.
Synopsys shares fell 2.6% to close at $457.95 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Rosenblatt analyst Blair Abernethy maintained a Buy rating with a price target of $660 on Feb. 25, 2025. This analyst has an accuracy rate of 72%.
- Morgan Stanley analyst Lee Simpson maintained an Overweight rating and cut the price target from $625 to $590 on Feb. 24, 2025. This analyst has an accuracy rate of 60%.
- Baird analyst Joe Vruwink maintained an Outperform rating and slashed the price target from $644 to $630 on Dec. 5, 2024. This analyst has an accuracy rate of 70%.
- Berenberg analyst Nay Soe Naing initiated coverage on the stock with a Buy rating and a price target of $660 on Oct. 15, 2024. This analyst has an accuracy rate of 69%.
- JP Morgan analyst Harlan Sur maintained an Overweight rating and boosted the price target from $655 to $685 on Aug. 22, 2024. This analyst has an accuracy rate of 80%.
Considering buying SNPS stock? Here’s what analysts think:

Read This Next:
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.